4) World Health Organization : Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications : Report of a WHO Consultation. Part 1 : Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, Switzerland, 1999. Available at : http://whqlibdoc.who.int/hq/1999/ (WHO NCD NCS 99. 2. pdf)
6) メタボリックシンドローム診断基準検討委員会 : メタボリックシンドロームの定義と診断基準. 日内会誌 94 (4) : 794-809, 2005.
9) UK Prospective Diabetes Study (UKPDS) Group : Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (9131) : 854-865, 1998.
10) Dormandy JA ; PROactive investigators : Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macro Vascular Events) : a randomised controlled trial. Lancet 366 (9493) : 1279-1289, 2005.
12) Despres JP, et al ; Rimonabant in Obesity-Lipids Study Group : Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353 (20) : 2121-2134, 2005.
14) 松沢佑次 : 生活習慣病の分子メカニズム. 日内会誌 94 (9) : 1705-1710, 2005.